NCT07011459 The Cooking for Health Optimization and Disease Prevention (CHOP) Trial
| NCT ID | NCT07011459 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tulane University |
| Condition | Cardiovascular Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 96 participants |
| Start Date | 2025-07-07 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 96 participants in total. It began in 2025-07-07 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Poor nutrition-related diseases disproportionately impact seniors and racial/ethnic minorities who are more likely to experience disparities in proper nutrition. Culinary medicine is a new evidence-based educational approach that blends the art of food and cooking with the science of medicine. Recently, culinary medicine is proposed by the 2020-2030 Strategic Plan for NIH Nutrition Research and national 'Food is Medicine (FIM)' Movement as potential solutions for improving healthy eating, creating social and emotional connections, and nutrition-related health equity. Built upon the well-established community teaching kitchen at The Goldring Center for Culinary Medicine (GCCM) at Tulane University and nearly 10 years of experience in delivering culinary education of Mediterranean diet (MedDiet), the investigators will conduct a randomized controlled trial (RCT) to test the feasibility and effectiveness of 3-month community teaching kitchen-based culinary education of MedDiet on improving cardiometabolic and mental health among racially and ethnically diverse seniors.
Eligibility Criteria
Inclusion Criteria: * Age 55 years or older * English speaking * Ability to provide informed consent. Exclusion Criteria: * Medical history of cardiovascular disease (CVD) or cancer. * Food allergies including, but not limited to, milk, eggs, shellfish, nuts, wheat or gluten, and soy. * Special diets including, but not limited to, Mediterranean, veganism, vegetarianism, gluten-free, and the ketogenic diet. * Current use of medications that could affect blood glucose and lipids levels including, but not limited to, insulins (Humalog, Novolog, insulin detemir, etc.), anti-diabetic medications (metformin, sulfonylureas, meglitinides, etc.), Ozempic. HAART, and beta blockers. * No children are involved. * No other vulnerable subjects will be involved.
Contact & Investigator
Lu Qi, PhD, MD
PRINCIPAL INVESTIGATOR
Tulane University
Frequently Asked Questions
Who can join the NCT07011459 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, up to 120 Years, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07011459 currently recruiting?
Yes, NCT07011459 is actively recruiting participants. Contact the research team at cmiller17@tulane.edu for enrollment information.
Where is the NCT07011459 trial being conducted?
This trial is being conducted at New Orleans, United States, New Orleans, United States.
Who is sponsoring the NCT07011459 clinical trial?
NCT07011459 is sponsored by Tulane University. The principal investigator is Lu Qi, PhD, MD at Tulane University. The trial plans to enroll 96 participants.